> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Guide on Animal Drug Biomarkers/Surrogate Endpoints
- URL: https://www.fdaweb.com/guide-on-animal-drug-biomarkers-surrogate-endpoints/
- Published: 2020-07-15T12:00:00.000Z
- Updated: 2026-09-14T16:21:17.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5147202

*Federal Register* notice: FDA has made available a draft guidance entitled “Biomarkers and Surrogate Endpoints in Clinical Studies Support Effectiveness of New Animal Drugs.” The document describes FDA’s current thinking on incorporating biomarkers and surrogate endpoints into proposed clinical investigation protocols and applications for new animal drugs. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2020-07-15/pdf/2020-15240.pdf?ref=fdaweb.com).